Article
CUL4B regulates thyroid cancer differentiation and treatment sensitivity by ubiquitinating ARID1A
11 Apr 2025
Abstract excerpt
• In the current study, for the first time, we dissected the role of CUL4B in TC. • We characterized that CUL4B ubiquitinates and degrades the SWI/SNF complex while competitively binding with ARID1A in the SWI/SNF complex to PAX8 at the transcription initiation site, ultimately leading to the downregulation of PAX8 expression. • A combination of CUL4B inhibitor, trametinib and dabrafenib may lead to more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
